Role of ultralow dose of naloxone as an adjuvant to fentanyl-bupivacaine in thoracic paravertebral block analgesia after modified radical mastectomy: Randomized controlled trial.

Autor:	Omara AF; Anesthesia, Intensive Care & Pain Medicine Department, Faculty of Medicine, Tanta University, Egypt. OR-CID: https://orcid.org/0000-0002-9025-632X., Ahmed SA; Anesthesia, Intensive Care & Pain Medicine Department, Faculty of Medicine, Tanta University, Egypt., Abusabaa MMA; Anesthesia, Intensive Care & Pain Medicine Department, Faculty of Medicine, Tanta University, Egypt.
Jazyk:	angličtina
Zdroj:	Journal of opioid management [J Opioid Manag] 2021 Sep-Oct; Vol. 17 (5), pp. 389-396.
DOI:	10.5055/jom.2021.0672
Abstrakt:	Objective: We evaluated the effect of the addition of 100 ng of naloxone to fentanyl-bupivacaine mixture used in thoracic paravertebral block (PVB) on the duration and the quality of post-mastectomy analgesia. Design: A randomized double-blinded trial. Setting: Oncology surgery unit. Patients and Participants: This study included 135 patients, aged 40-60 years of either sex presented for elective unilateral-modified radical mastectomy. Interventions: Patients were divided randomly into three groups: group I, received 0.3 mL/kg of 0.25 percent bupivacaine; group II, received 0.3 mL/kg of 0.25 percent bupivacaine, fentanyl 50 µg, and naloxone 100 ng; group III, received 0.3 mL/kg of 0.25 percent bupivacaine and fentanyl 50 µg. Main Outcome Measure(s): The visual analog scale was assessed immediately post-operative, every 2 hours till 12 hours, and then every 6 hours for 24 hours; the time of first and total amount of rescue analgesia and side effects during the first 24 hours were recorded. Results: Group II showed a significant prolonged analgesia with a delayed first request of rescue analgesia and lower amount of morphine (592.1 ± 14.9 minutes and 7.28 ± 7.81 mg, respectively) than groups I (127.7 ± 35.1 minutes and 19.84 ± 2.56 mg, respectively) and III (232.2 ± 9.27 minutes and 13.52 ± 1.74 mg, respectively) as p < 0.001. Conclusion: Using naloxone as additives in PVB has been promising and effective in controlling post-mastectomy pain.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu